Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling.

Cancers (Basel) · 2025 · PMC12427376 · PMID 40940957

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

All p -values are two-tailed, and significance was represented in p -values < 0.001 (*** highly significant), <0.01 (** very significant), <0.05 (* significant), and >0.05 ( ns non-significant). 3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.